Tuesday, August 4, 2026

Fire on Air Busan Flight at Gimhae Airport Fully Extinguished, All 176 Passengers Safely Evacuated

A fire on an Air Busan aircraft at Gimhae Airport led to an emergency evacuation of 176 people, with minor injuries reported.

Samsung Asset Management Rebrands ETF to Simplify Investor Understanding

Samsung Asset Management renames its ETF to enhance investor understanding while maintaining its investment strategy in U.S. semiconductors.

Clash in the Assembly: South Korea’s Political Crisis Deepens

On the 26th, the Presidential Office criticized...

Tag: Nesuparib

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

Nesuparib: The Revolutionary Dual-Inhibitor for Pancreatic Cancer – Can It Outperform Existing Treatments?

Nesuparib shows promise in inhibiting pancreatic cancer metastasis, offering hope for patients regardless of BRCA mutation status.

Nesuparib: The Game-Changing Cancer Treatment for Small Cell Lung Cancer Revealed at AACR 2026

Onconic Therapeutics reveals Nesuparib's promising preclinical results for small cell lung cancer, outperforming existing treatments significantly.

Next-Gen Cancer Drug Nesuparib: How It Outperforms Olaparib in SCLC and Pancreatic Cancer

Onconic Therapeutics will present Nesuparib research at AACR 2026, showcasing its potential for various cancers and overcoming PARP inhibitor limitations.

Nesuparib: A Game-Changer in Cancer Treatment? Key Findings from AACR 2026

Onconic Therapeutics' Nesuparib shows promising results against small cell lung and pancreatic cancers, highlighting its competitive edge.

Nesuparib vs. Traditional Treatments: Will This New Dual-Target Cancer Drug Change the Game for Ovarian Cancer?

Onconic Therapeutics advances Nesuparib into Phase 2 trials for ovarian cancer, aiming to validate a novel re-maintenance therapy approach.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.